dc.contributor.author |
Mahesh, R. |
|
dc.date.accessioned |
2023-11-23T07:18:54Z |
|
dc.date.available |
2023-11-23T07:18:54Z |
|
dc.date.issued |
2016-06 |
|
dc.identifier.uri |
https://journals.lww.com/ijnp/Fulltext/2016/06020/Antidepressant__and_anxiolytic_like_effect_of.5.aspx |
|
dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13238 |
|
dc.description.abstract |
Depression and anxiety are among the most common and prevalent forms of mental disorder. The 5-hydroxytryptamine3 (5-HT 3) receptor antagonists modulate serotonergic pathways and show antidepressant- and anxiolytic-like effect in various animal models of depression. The present study was designed to investigate the antidepressant and anxiolytic potential of 2-[4-(3-chlorophenyl) piperazin-1-yl]- 1,8-naphthyridine-3-carboxylic acid (7e), a novel 5-HT 3 receptor antagonist in rodent behavioral models of depression and anxiety. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Wolters Kluwer |
en_US |
dc.subject |
Pharmacy |
en_US |
dc.subject |
Antidepressant |
en_US |
dc.subject |
Anxiolytic test battery |
en_US |
dc.subject |
Antidepressant |
en_US |
dc.subject |
Depression |
en_US |
dc.title |
Antidepressant- and anxiolytic-like effect of novel 5-hydroxytryptamine3 receptor antagonist 2-[4-(3-chlorophenyl) piperazin-1-yl]-1,8-naphthyridine -3-carboxylic acid (7e)- An approach using rodent behavioral antidepressant and anxiolytic test battery |
en_US |
dc.type |
Article |
en_US |